315 related articles for article (PubMed ID: 32692719)
1. PRDX2 removal inhibits the cell cycle and autophagy in colorectal cancer cells.
Zheng X; Wei J; Li W; Li X; Wang W; Guo J; Fu Z
Aging (Albany NY); 2020 Jul; 12(16):16390-16409. PubMed ID: 32692719
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Cancer Lett; 2014 Feb; 343(2):190-9. PubMed ID: 24125860
[TBL] [Abstract][Full Text] [Related]
3. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
5. Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress.
Lu W; Fu Z; Wang H; Feng J; Wei J; Guo J
Mol Cell Biochem; 2014 Feb; 387(1-2):261-70. PubMed ID: 24234423
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
7. Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.
Zhang S; Fu Z; Wei J; Guo J; Liu M; Du K
Med Oncol; 2015 Jan; 32(1):414. PubMed ID: 25471788
[TBL] [Abstract][Full Text] [Related]
8. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
Wang W; Wei J; Zhang H; Zheng X; Zhou H; Luo Y; Yang J; Deng Q; Huang S; Fu Z
Cell Death Dis; 2021 Jun; 12(6):605. PubMed ID: 34117220
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients.
Peng L; Wang R; Shang J; Xiong Y; Fu Z
Oncotarget; 2017 Feb; 8(9):15057-15070. PubMed ID: 28125800
[TBL] [Abstract][Full Text] [Related]
10. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
[TBL] [Abstract][Full Text] [Related]
11. Upregulated NTF4 in colorectal cancer promotes tumor development via regulating autophagy.
Yang Z; Chen Y; Wei X; Wu D; Min Z; Quan Y
Int J Oncol; 2020 Jun; 56(6):1442-1454. PubMed ID: 32236587
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long noncoding RNA urothelial carcinoma associated 1 inhibits colorectal cancer cell proliferation and promotes apoptosis via modulating autophagy.
Song F; Li L; Liang D; Zhuo Y; Wang X; Dai H
J Cell Physiol; 2019 May; 234(5):7420-7434. PubMed ID: 30362538
[TBL] [Abstract][Full Text] [Related]
13. A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer.
Liu Q; Guo L; Qi H; Lou M; Wang R; Hai B; Xu K; Zhu L; Ding Y; Li C; Xie L; Shen J; Xiang X; Shao J
Cell Death Dis; 2021 Jul; 12(7):683. PubMed ID: 34234118
[TBL] [Abstract][Full Text] [Related]
14. Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
Chuerduangphui J; Ekalaksananan T; Heawchaiyaphum C; Vatanasapt P; Pientong C
PLoS One; 2020; 15(12):e0242465. PubMed ID: 33332365
[TBL] [Abstract][Full Text] [Related]
15. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Oxiconazole against Colorectal Cancer via PRDX2-mediated Autophagy Arrest.
Shi J; Zhou L; Huang HS; Peng L; Xie N; Nice E; Fu L; Jiang C; Huang C
Int J Biol Sci; 2022; 18(9):3747-3761. PubMed ID: 35813474
[TBL] [Abstract][Full Text] [Related]
17. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
18.
Athamneh K; Alneyadi A; Alsamri H; Alrashedi A; Palakott A; El-Tarabily KA; Eid AH; Al Dhaheri Y; Iratni R
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32155920
[TBL] [Abstract][Full Text] [Related]
19. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
20. The critical role of peroxiredoxin-2 in colon cancer stem cells.
Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Fu Z
Aging (Albany NY); 2021 Mar; 13(8):11170-11187. PubMed ID: 33819194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]